Taiwan
World
China
Life
AI & Semiconductor
Business
Taiwan
World
China
Life
AI & Semiconductor
Business
Taiwan
World
China
Life
AI & Semiconductor
Business
Home
Hepatocellular carcinoma
#
Hepatocellular carcinoma
About 5 search results
Sort by Date
Business
PR Newswire
CityUHK researchers reveal how fructose can suppress liver cancer, opening a new therapeutic avenue
HONG KONG
PR Newswire
2026-10-26 17:50
Fructose
Liver cancer
Hepatocellular carcinoma
Business
PR Newswire
Geneos Therapeutics Initiates IMPACT31 Phase 2 Randomized Clinical Trial Evaluating Neoantigen-Targeted Personalized DNA Immunotherapy for Cancer
PHILADELPHIA
PR Newswire
2026-10-21 21:10
Geneos Therapeutics
personalized DNA immunotherapy
IMPACT31
Business
PR Newswire
Acepodia Announces FDA Clearance of IND Application for ACE723, a Novel Dual-Payload Antibody-Drug Conjugate
FDA clearance enables initiation of a Phase 1 clinical trial and advances the first AD2C-generated candidate into clinical development
PR Newswire
2026-09-04 19:00
Acepodia
ACE723
antibody-drug conjugate
Business
PR Newswire
ASCO 2026 | Oricell's GPC3 CAR-T Ori-C101 Hits 66.7% ORR in Late-Line HCC, Signaling Best-in-Class Potential
CHICAGO
PR Newswire
2026-06-01 10:37
Ori-C101
CAR-T therapy
Hepatocellular carcinoma
Life
News
Taiwan
Beating Hep C Is Not Enough: Fatty Liver Keeps Liver Cancer Risk High, NTUH Study Warns
Successfully clearing the hepatitis C virus is a major medical milestone — but it does not fully close the door on liver cancer. A large-scale, long-term cohort study led by resear......
Huang Tian-ru
2026-05-19 18:00
Hepatitis C
Fatty Liver
NTU Hospital